Excessive expression of PSMD14 is associated with higher TNM stage in lung adenocarcinoma, increased vascular invasion in hepatocellular carcinoma, higher pathological grade in prostate cancer, and poor survival in patients with colorectal cancer or breast cancer [8, 9, 11, 13, 14, 15]. Here, PSMD14 is linked to hepatocellular carcinoma.